24. Dr. Thomas Schreitmueller - F. Hoffman-La Roche (on behalf of IFPMA)
EpiVax_ISPRI_Non_Confidential_June2014_BIO2014
EpiVax_ISPIR_VS_IEDB_comparison_Immunogenicity_of_protein_drugs_Mar2014